Compare LCTX & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LCTX | MNTK |
|---|---|---|
| Founded | 1990 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.4M | 267.6M |
| IPO Year | 1996 | 2020 |
| Metric | LCTX | MNTK |
|---|---|---|
| Price | $1.06 | $2.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $6.25 | $1.80 |
| AVG Volume (30 Days) | ★ 856.7K | 263.7K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $14,556,000.00 | ★ $176,382,000.00 |
| Revenue This Year | $109.40 | $18.55 |
| Revenue Next Year | N/A | $12.68 |
| P/E Ratio | ★ N/A | $146.00 |
| Revenue Growth | ★ 53.24 | 0.37 |
| 52 Week Low | $1.00 | $1.07 |
| 52 Week High | $2.09 | $2.73 |
| Indicator | LCTX | MNTK |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 56.44 |
| Support Level | $1.02 | $1.49 |
| Resistance Level | $1.18 | N/A |
| Average True Range (ATR) | 0.05 | 0.17 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 37.84 | 49.26 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.